Anzeige
Mehr »
Login
Montag, 30.12.2024 Börsentäglich über 12.000 News von 681 internationalen Medien
Die Zukunft ist jetzt - KI macht den Unterschied! Smarter. Schneller. Erfolgreicher!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma Dive

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13.12.Dietmar Berger is Gilead's new CMO; Padlock investors sue Bristol Myers
13.12.AbbVie to acquire Roche spinout Nimble in immune drug deal
12.12.Editas to lay off staff after search for sickle cell partner comes up empty
12.12.FDA flags additional injury risk for Intercept's liver drug
12.12.'Research that's desperately needed': White House conference spotlights women's health
12.12.Keros shares collapse on 'unanticipated' setback for lung disease drug
11.12.GLP-1 drug compounding is in limbo. Will the FDA draw out its decision?
11.12.With new data, Lilly sets pace for next wave of breast cancer drugs
11.12.Q32 Bio battered by study failure of immune drug
11.12.BenevolentAI restructures; Lilly preps $15B buyback program
11.12.Chroma, Nvelop merge to marry genetic medicine 'cargo' to delivery
10.12.ASH24: Leukemia drug sequencing, sickle cell questions and a new kind of CAR-T
10.12.UniQure shares soar on chance of speedy approval for Huntington's therapy
10.12.NewAmsterdam drug shows 'unexpected' signs of protecting the heart in latest study
09.12.ASH24: Darzalex in smoldering myeloma, Merck's ADC data and Novo's sickle cell drug
09.12.Gene therapy uptake in sickle cell stays slow, despite patient interest
09.12.Dimension gets $500M to bankroll biotech's convergence with tech
09.12.Endometriosis drug research, long underfunded, confronts familiar problems in women's health
09.12.What's behind pharma's growth boost?
09.12.Why bioscience and healthcare innovators are looking to Phoenix
09.12.Clinical services organizations are critical to the future of pharma in the APAC market
06.12.With conflicts of interest in focus, Trump's pick to run FDA could face scrutiny of his own industry ties
06.12.Lilly adds to obesity drug production push with $3B investment
06.12.AstraZeneca, Daiichi build cancer drug case; Amgen invests $1B
05.12.Atlas doubles down on 'disciplined' biotech investing with latest fundraise